Erin E. Lanciani
Human Resources Officer at SAGE THERAPEUTICS, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeff Jonas | M | 71 | 11 years | |
Steven Paul | M | 73 | 14 years | |
Phil Holzer | M | 48 | 11 years | |
Kartik Kiran Shah | M | 46 |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | 10 years |
Geno Germano | M | 63 | 8 years | |
Barry Greene | M | 60 | 4 years | |
Amy Schacterle | M | - | 9 years | |
Michael Wyand | M | 68 |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | 7 years |
Vishal Bansal | M | 50 |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | 10 years |
Jessica Federer | F | - | 1 years | |
Anne Cook | F | 62 | 9 years | |
Heinrich Schlieker | M | - | 9 years | |
Kimi Iguchi | F | 61 | 11 years | |
Elizabeth Barrett | F | 62 | 5 years | |
Sharon Cload | M | - |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | 16 years |
George Golumbeski | M | 67 | 5 years | |
Michael Cola | M | 64 | 10 years | |
Jim Frates | M | 56 | 10 years | |
Louis Schmukler | M | - | 13 years | |
Tammy J. Phinney | F | - | 4 years | |
Laura Gault | F | - | 2 years | |
Mike Quirk | M | - | 10 years | |
Igor Koralnik | M | - |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | - |
Glen Frick | M | 57 |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | - |
Alex Smith | M | 39 |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | - |
Julianne Averill | F | 39 |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | 3 years |
Jennifer Fitzpatrick | F | - | - | |
Matt Lasmanis | M | - | 4 years | |
Zack Newman | M | - | 11 years | |
Murray B. Stein | M | - |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | - |
Lindsey McClelland | F | - |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | - |
Vanessa Procter | F | - | - | |
Christopher Benecchi | M | - | 3 years | |
Anne-Kelledy Manson | F | - |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | 17 years |
Matthew Henson | M | - | - | |
Teofilo Raad | M | 54 |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Marc Beer | M | 59 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 11 years |
Kevin Starr | M | 61 | 13 years | |
Thomas Lynch | M | 63 | 5 years | |
John E. Celentano | M | 64 | 31 years | |
Cynthia Fisher | F | 63 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 4 years |
Asha Nayak | M | - | 3 years | |
Christopher Silber | M | - | 3 years | |
Clifford Bechtold | M | - |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | 4 years |
Steven Burke | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Frank Sanders | M | - | - | |
Michael Cloonan | M | 53 | 4 years | |
Eric Fencl | M | 61 |
Outsourcing Solutions, Inc.
Outsourcing Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Outsourcing Solutions, Inc. provides business process outsourcing services. The firm specializes in accounts receivable management services. Its services include asset-backed securities, distressed debt portfolio management, post-charge off recovery, portfolio acquisition & management, legal network management and bankruptcy services. Outsourcing Solutions was founded in 1995 and is headquartered in Chesterfield, MO. | 10 years |
Gerald Storch | M | 67 | 12 years | |
Charles Sigal | M | 72 | 16 years | |
Howard H. Pien | M | 66 | 3 years | |
Robert Nelsen | M | 60 | 3 years | |
Mark Leuchtenberger | M | 67 |
Therion Biologics Corp.
Therion Biologics Corp. Pharmaceuticals: MajorHealth Technology Therion Biologics Corp. developed therapeutic vaccines for cancer patients. The company was founded on May 5, 1991 and was headquartered in Cambridge, MA. | 4 years |
Leif Valdemar Johansson | M | 73 | 13 years | |
John Mendlein | M | 64 |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | 3 years |
Jim Doherty | M | 56 | 12 years | |
Béatrice J. Cazala | F | 67 | 32 years | |
Robert Williams | M | 75 | 7 years | |
Dinesh C. Paliwal | M | 67 | 8 years | |
Louis J. Freeh | M | 74 | 8 years | |
Anthony Hooper | M | 69 | 15 years | |
Lena Elisabeth Svanberg | M | 63 | 7 years | |
Scott Gunther | M | 57 | 4 years | |
Desiree Luthman | M | 65 | 2 years | |
Linda Kozick | F | 66 | 4 years | |
Karen Murphy Santiago | F | 53 | 10 years | |
Ronald Peck | M | 58 | 4 years | |
Kevin Trapp | M | - | 2 years | |
John Shamsey | M | - | 6 years | |
Nancy Phelan | F | 55 | 5 years | |
Mark Neumann | M | - | 26 years | |
Dolca Thomas | M | 53 | 4 years | |
Dimitry Nuyten | M | - | 5 years | |
Paul Daruwala | M | 55 | 2 years | |
David Cohen | M | - | 8 years | |
Karen LaRochelle | F | 57 | 20 years | |
Quentin Roach | M | 57 | 3 years | |
Randall Owen | M | - | 6 years | |
Robert G. Petit | M | 64 | 5 years | |
Vered Bisker-Leib | M | 53 | 5 years | |
Mark Trudeau | M | 62 | 11 years | |
Carlo de Notaristefani | M | 67 | 7 years | |
Lynn H. Clark | F | 66 | 8 years | |
Holly Tyson | F | 52 | 8 years | |
Mark Hollywood | M | 55 | 9 years | |
Frances K. Heller | F | 57 | - | |
Andres Gutiérrez | M | 63 | 3 years | |
Kelly Schick | F | 44 | - | |
Michael Burgess | M | 61 | - | |
Pankaj Mohan | M | 60 | 2 years | |
Wendy Dixon | M | 68 | 8 years | |
Cheryl Capps | F | 62 | 13 years | |
Linda Jordan | F | - | - | |
Sheila Gujrathi | M | 53 | 3 years | |
Kyu-Sung Lee | M | 64 | 5 years | |
Ann Powell | F | 58 | 10 years | |
Jill DeSimone | F | 68 | 32 years | |
Jon Wigginton | M | 62 | 5 years | |
Danielle Halstrom | F | - | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Erin E. Lanciani
- Personal Network